Clinical trial
Prevention of Coronary Microvascular Dysfunction Post-PCI by Intracoronary Nicardipine
NCT03184155 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Coronary Microvascular Dysfunction Post-PCI by Intracoronary Nicardipine
- Lead sponsor
- Thomas Jefferson University
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- December 31, 2025
- Completion date
- December 31, 2026
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.